Table 3 Primary outcome
From: Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema
Resolved (n = 310) Mean ± StdDev | Resolved (n = 310) Median (Interquartile Range) | Not resolved (n = 28) Mean ± StdDev | Not resolved (n = 28) Median (Interquartile Range) | p-value | |
|---|---|---|---|---|---|
Total antibiotic duration (days) | 21.5 ± 20.2 | 17.0 (11.0–28.0) | 16.4 ± 14.0 | 14 (7.0–19.0) | 0.071 |
IV antibiotic duration (days) | 12.4 ± 15.0 | 7.0 (4.0–16.0) | 12.6 ± 12.8 | 9.0 (3.0–17.5) | 0.970 |
Anti-anaerobic antibiotic duration (days) | 11.8 ± 13.7 | 8.0 (0–17.0) | 6.9 ± 11.9 | 3.0 (0–7.0) | 0.053 |